Purpose: Linac parameters potentially influencing the delivery quality of IMRT and VMAT plans are investigated with respect to threshold ranges, consequently to be considered in a linac based quality assurance procedure. Three commercially available 2D arrays are used to further investigate the influence of the measurement device. 
During the last years, measurement devices have largely improved with regard to resolution [1] [2] [3] and needs for rotational techniques like VMAT. 4 In addition, improvements in tests for the correct beam model parameters were proposed. [5] [6] [7] [8] Nevertheless, the evaluation of treatment plan QA is still cumbersome as shown by ongoing discussions about the widely used gamma-evaluation method itself, the optimal evaluation parameters and the comparison between different measurement devices. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Bypassing the measurement, linac log files, which monitor each single parameter of the linac, can be used to reconstruct the delivered dose. [19] [20] [21] As linac log files monitor surrogate parameters for absolute linac values, miscalibrations could stay undetected without tight linac QA. Furthermore, the sampling rate might be too low in some cases to reveal errors in fast changing parameters like leaf acceleration, which was shown to have a large impact on good agreement between calculation and delivery. 22, 23 Besides plan-individual measurements and evaluation of linaclog files, delivery subsystems such as MLC movement or dose rate stability can be analyzed separately in a linac based QA approach.
This means that the complexity of especially VMAT is split into its single significant components and that measurements are conducted without devices that are developed especially for the rotational needs in VMAT. Instead, known devices (e.g. 2D arrays) are used. During commissioning, this simplification points out general linac parameters that are potentially subject to influence the delivery quality of IMRT and VMAT and thus should be respected throughout the treatment plan generation. As a consequence, 
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2.A | Complexity levels in IMRT and VMAT QA
We break down the complexity of modulated radiation therapy techniques into three categories to investigate threshold ranges that may potentially limit plan delivery quality. These comprise linac parameters which should be included into plan generation as well as measurement shortcomings using 2D arrays:
1. Simple static QA tests (Table 1A) Table 2 .
All measurements were carried out using a 6 MV photon beam of an Elekta Synergy linac equipped with an Agility TM multi-leaf-collimator (MLC, leaf width: 5 mm). Before each measurement session, the arrays were dose calibrated at 5 cm depth.
For the simple basic QA tests (A) and the leaf-dose-rate-interplay measurements (C1) the arrays were setup isocentric (sourceto-detector-distance SDD = 100 cm), with 10 cm additional backscatter material (RW3, PTW) and the measurement depth was raised to 5 cm (water equivalent) for all arrays using RW3. For the penumbra measurements, the arrays were shifted mm-wise 10 times in in-or crossplane direction using a robotic homogeneity of the profiles decreases for low doses (≤8 MU) for all arrays as well as for low dose rates (≤60 MU/min), especially when using Mc. This effect is more pronounced for the crossplane profiles.
Also for less influence of the profile homogeneity to the measurements, a calibration of the dose profile around the most often used dose rate could improve the overall delivery quality. Remarkable is that for Oc, not exactly flat RW3 slabs can disturb the measurement.
Due to a minimal convex shape, the pressure on ion chambers in the middle of the arrays reduces the active volume and therefore the measured dose. This can be avoided by either flipping the convex slab 180°or by introducing a minimal space of about 1 mm between the array and the slabs.
3.A.4 | Summation of small doses
All summed doses were smaller than the dose measured for 
3.A.6 | Dose gradient measurement
As a surrogate for dose gradients, the penumbra of a 10 cm 9 10 cm field was used (Fig. 3) . more pronounced compared to the ion chamber arrays (Fig. 4) . 
3.B.2 | Dynamic sweeping gap
The relative dose of the unmanipulated 2 cm wide sweeping gap with 100 MU compared to a 20 9 20 cm² field is 9.93%, 9.86%, and 9.97% for Mc, Oc, and Mx respectively ( 
3.B.3 | Chair test
Depending on how dose is delivered (leaf travel, transmission, or leaf gap only), the relative dose of the arrays differs, with Mc showing the lowest dose for all regions. In regions with leaf travel or leaf gap only, the deviation between the arrays is ≤1%. In the region with transmission only, the deviation is ≤2% (Fig. 6 ). This (Fig. 7) . . Dose, dose rate and field size dependence as were described by these authors are supported by our data, even though the non-linearity for very small doses in the linac ramp up was either not studied before or described to a different reference and also field sizes below 2 9 2 cm² we not studied.
3.C.2 | Interplay of dose rate and gantry movement
This study therefore contributes to more detailed understanding of array behavior in regions of small dose, dose rate, and field size, including effects of differences in profile homogeneity in static and dynamic delivery. Including three of the most often used 2D arrays Fig. 1(a) ]. In general, plan-individual QA focuses the challenge of finding the correct pass criteria. On the one hand, using the popular method of gamma-evaluation and subsequent pass rate analysis, 26 one can argue about the correct distance-to-agreement and dose criteria or pass rate, that has to be used. 2, 9, 10, 12, 13, 15, 18 On the other hand, one can question this method in general, 27, 28 as there might be a lack of correlation between the results of the gamma-analysis and the clinical implication. 9, 11, 13, 14, 27, [29] [30] [31] [32] Furthermore, the optimal criteria might depend on the measurement device, 11, [16] [17] [18] which is supported by our results. This tolerance may depend on the used array, the exact composition of dose distribution as well as the used linac. However, increasing tolerances will also mask important shortcomings of the plan and its delivery. Therefore, this procedure will not only be cumbersome but also misleading with regard to identify important delivery errors. 
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